001     131643
005     20240228145611.0
024 7 _ |a 10.1038/s41467-017-02177-w
|2 doi
024 7 _ |a pmid:29259247
|2 pmid
024 7 _ |a pmc:PMC5736667
|2 pmc
024 7 _ |a altmetric:30667048
|2 altmetric
037 _ _ |a DKFZ-2017-06275
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Lipka, Daniel B
|0 0000-0001-5081-7869
|b 0
|e First author
245 _ _ |a RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
260 _ _ |a London
|c 2017
|b Nature Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533643586_10366
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a (* Co-first authors)
520 _ _ |a Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative disorder of early childhood characterized by mutations activating RAS signaling. Established clinical and genetic markers fail to fully recapitulate the clinical and biological heterogeneity of this disease. Here we report DNA methylome analysis and mutation profiling of 167 JMML samples. We identify three JMML subgroups with unique molecular and clinical characteristics. The high methylation group (HM) is characterized by somatic PTPN11 mutations and poor clinical outcome. The low methylation group is enriched for somatic NRAS and CBL mutations, as well as for Noonan patients, and has a good prognosis. The intermediate methylation group (IM) shows enrichment for monosomy 7 and somatic KRAS mutations. Hypermethylation is associated with repressed chromatin, genes regulated by RAS signaling, frequent co-occurrence of RAS pathway mutations and upregulation of DNMT1 and DNMT3B, suggesting a link between activation of the DNA methylation machinery and mutational patterns in JMML.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Witte, Tania
|0 0000-0003-4287-1608
|b 1
|e First author
700 1 _ |a Toth, Reka
|0 P:(DE-He78)cd2ec3f2ae9b2178f113e0f2ed15fc48
|b 2
|u dkfz
700 1 _ |a Yang, Jing
|0 P:(DE-He78)f408e260b87a089b925516846cebe59c
|b 3
|u dkfz
700 1 _ |a Wiesenfarth, Manuel
|0 P:(DE-He78)1042737c83ba70ec508bdd99f0096864
|b 4
|u dkfz
700 1 _ |a Nöllke, Peter
|0 0000-0002-0281-4732
|b 5
700 1 _ |a Fischer, Alexandra
|b 6
700 1 _ |a Brocks, David
|0 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8
|b 7
|u dkfz
700 1 _ |a Gu, Zuguang
|0 P:(DE-He78)73316f3cd41c27508dbb6f4c5e7e7a8a
|b 8
|u dkfz
700 1 _ |a Park, Jeongbin
|0 P:(DE-He78)92e094eac4fff11dc500bf29667bbc8e
|b 9
|u dkfz
700 1 _ |a Strahm, Brigitte
|b 10
700 1 _ |a Wlodarski, Marcin
|0 0000-0001-6638-9643
|b 11
700 1 _ |a Yoshimi, Ayami
|b 12
700 1 _ |a Claus, Rainer
|b 13
700 1 _ |a Lübbert, Michael
|b 14
700 1 _ |a Busch, Hauke
|b 15
700 1 _ |a Boerries, Melanie
|b 16
700 1 _ |a Hartmann, Mark
|0 0000-0002-4072-4658
|b 17
700 1 _ |a Schönung, Maximilian
|0 0000-0002-9778-9698
|b 18
700 1 _ |a Kilik, Umut
|0 P:(DE-He78)076ea1a7c623ab7e1b9a1c7824a12963
|b 19
|u dkfz
700 1 _ |a Langstein, Jens
|0 P:(DE-He78)6c69bbe6493efcf728dd48d0257f4eda
|b 20
|u dkfz
700 1 _ |a Wierzbinska, Justyna A
|0 0000-0001-5536-3501
|b 21
700 1 _ |a Pabst, Caroline
|b 22
700 1 _ |a Garg, Swati
|b 23
700 1 _ |a Catalá, Albert
|0 0000-0003-0133-1752
|b 24
700 1 _ |a De Moerloose, Barbara
|b 25
700 1 _ |a Dworzak, Michael
|b 26
700 1 _ |a Hasle, Henrik
|0 0000-0003-3976-9231
|b 27
700 1 _ |a Locatelli, Franco
|b 28
700 1 _ |a Masetti, Riccardo
|0 0000-0002-1264-057X
|b 29
700 1 _ |a Schmugge, Markus
|b 30
700 1 _ |a Smith, Owen
|b 31
700 1 _ |a Stary, Jan
|b 32
700 1 _ |a Ussowicz, Marek
|b 33
700 1 _ |a van den Heuvel-Eibrink, Marry M
|b 34
700 1 _ |a Assenov, Yassen
|0 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c
|b 35
|u dkfz
700 1 _ |a Schlesner, Matthias
|0 0000-0002-5896-4086
|b 36
700 1 _ |a Niemeyer, Charlotte
|b 37
700 1 _ |a Flotho, Christian
|b 38
700 1 _ |a Plass, Christoph
|0 0000-0003-2554-3952
|b 39
773 _ _ |a 10.1038/s41467-017-02177-w
|g Vol. 8, no. 1, p. 2126
|0 PERI:(DE-600)2553671-0
|n 1
|p 2126
|t Nature Communications
|v 8
|y 2017
|x 2041-1723
909 C O |p VDB
|o oai:inrepo02.dkfz.de:131643
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 0000-0001-5081-7869
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0000-0003-4287-1608
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)cd2ec3f2ae9b2178f113e0f2ed15fc48
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)f408e260b87a089b925516846cebe59c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)1042737c83ba70ec508bdd99f0096864
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)73316f3cd41c27508dbb6f4c5e7e7a8a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)92e094eac4fff11dc500bf29667bbc8e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 0000-0002-4072-4658
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 0000-0002-9778-9698
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)076ea1a7c623ab7e1b9a1c7824a12963
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)6c69bbe6493efcf728dd48d0257f4eda
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 0000-0001-5536-3501
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 0000-0002-5896-4086
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2015
920 1 _ |0 I:(DE-He78)C010-20160331
|k C010
|l Epigenomik und Krebsrisikofaktoren
|x 0
920 1 _ |0 I:(DE-He78)B080-20160331
|k B080
|l Theoretische Bioinformatik
|x 1
920 1 _ |0 I:(DE-He78)B240-20160331
|k B240
|l Bioinformatik und Omics Data Analytics
|x 2
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 3
920 1 _ |0 I:(DE-He78)L601-20160331
|k L601
|l DKTK Freiburg
|x 4
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C010-20160331
980 _ _ |a I:(DE-He78)B080-20160331
980 _ _ |a I:(DE-He78)B240-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)L601-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21